Position in HRMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,717,834
-$4,348,763 QoQ
Shares Held
514,085
-37.6% QoQ
Ownership
0.883%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 328 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. HRMY ranks #65 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in HRMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,717,834 | 514,085 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $23,066,597 | 823,513 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,460,087 | 199,361 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,795,658 | 174,008 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $6,125,658 | 193,850 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $16,090,409 | 484,797 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $8,116,696 | 235,882 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,217,120 | 230,428 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $4,127,434 | 136,806 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $1,438,532 | 42,839 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $3,969,797 | 122,904 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $2,584,502 | 78,868 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,628,368 | 103,108 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,769,433 | 54,194 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $5,113,553 | 92,805 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $5,150,260 | 116,285 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $4,728,884 | 96,963 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $1,232,933 | 25,343 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $951,978 | 22,326 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $364,900 | 9,520 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $286,166 | 10,137 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $565,709 | 17,122 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $704,489 | 19,488 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $13,085 | 386 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||